InvestorsHub Logo
Post# of 252867
Next 10
Followers 5
Posts 997
Boards Moderated 0
Alias Born 07/29/2010

Re: DewDiligence post# 115930

Sunday, 03/06/2011 11:57:22 PM

Sunday, March 06, 2011 11:57:22 PM

Post# of 252867

...the fact that Teva has agreed to a drawn-out timeline in which a trial could not start until 2013 suggests that Teva has no expectation of getting FDA approval in the next two years...

Excuse my denseness, but I read the entire document you linked to and I can't figure out how you arrive at the conclusion that TEVA doesn't expect FDA approval in the next two years. Can you explain your rationale?

Unless I'm totally misunderstanding things, (which, when legal matters are involved is more than possible) TEVA has managed to kick the can more than a year down the road - which I count as a win for TEVA - and I imagine they will portray it as such.

Heck, why wouldn't TEVA celebrate? A guarantee of no trial for 1+ years equates to no expectation of t-enox approval on TEVA's part?

I'm plain mystified by your interpretation.

Thanks in advance for your reply.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.